{
  "_description": "Sickle Cell Disease (HbS) parameters",
  "_citations": {
    "polymerization": "Eaton WA, Hofrichter J. Blood. 1987;70:1245-1266",
    "p50_shift": "Bunn HF. N Engl J Med. 1997;337:762-769",
    "kinetics": "Ferrone FA. J Mol Biol. 2004;341:843-855",
    "oxidative_stress": "Hebbel RP et al. Semin Hematol. 1990;27:51-69"
  },
  "_units": {
    "p50": "mmHg",
    "saturation": "fraction (0-1)",
    "rates": "per second"
  },

  "hbs_p50_mmHg": {
    "value": 31.0,
    "_comment": "P50 for HbS (lower O2 affinity than HbA)",
    "_reference": "Eaton 1987"
  },

  "hbs_hill_coefficient": {
    "value": 2.6,
    "_comment": "Slightly reduced cooperativity for HbS",
    "_reference": "Bunn 1997"
  },

  "hba_p50_mmHg": {
    "value": 26.8,
    "_comment": "Normal HbA P50 for comparison"
  },

  "polymerization_critical_saturation": {
    "value": 0.35,
    "_comment": "O2 saturation below which polymerization begins",
    "_reference": "Eaton 1987"
  },

  "polymerization_rate_per_sec": {
    "value": 0.1,
    "_comment": "Rate constant for polymer formation after nucleation"
  },

  "depolymerization_rate_per_sec": {
    "value": 0.5,
    "_comment": "Rate constant for polymer dissolution upon reoxygenation"
  },

  "delay_time_exponent": {
    "value": 15.0,
    "_comment": "Cooperative nucleation exponent (delay ~ [HbS]^-15)",
    "_reference": "Ferrone 2004"
  },

  "stiffness_multiplier_full_polymer": {
    "value": 10.0,
    "_comment": "Sickled cells are ~10x stiffer than normal",
    "_reference": "Evans 1984"
  },

  "chronic_oxidative_stress": {
    "value": 1.8,
    "_comment": "Baseline oxidative stress multiplier for HbSS",
    "_reference": "Hebbel 1990"
  },

  "nadph_consumption_sickling": {
    "value": 0.0002,
    "_comment": "Additional NADPH consumption during sickling (mM/s)"
  },

  "genotypes": {
    "_description": "HbS fraction by genotype",
    "HbAA": {
      "hbs_fraction": 0.0,
      "clinical": "Normal"
    },
    "HbAS": {
      "hbs_fraction": [0.30, 0.45],
      "clinical": "Sickle trait (carrier, usually asymptomatic)"
    },
    "HbSC": {
      "hbs_fraction": [0.45, 0.55],
      "clinical": "Sickle-hemoglobin C disease (moderate)"
    },
    "HbS_beta_thal": {
      "hbs_fraction": [0.60, 0.90],
      "clinical": "Sickle-beta thalassemia (variable severity)"
    },
    "HbSS": {
      "hbs_fraction": [0.90, 1.0],
      "clinical": "Sickle cell disease (severe)"
    }
  },

  "validation_targets": {
    "_description": "Expected oxygen binding parameters by genotype",
    "HbAA": {
      "p50_mmHg": 26.8,
      "polymerization_at_pO2_40": "none"
    },
    "HbAS": {
      "p50_mmHg": [27.5, 28.5],
      "polymerization_at_pO2_40": "minimal"
    },
    "HbSS": {
      "p50_mmHg": [30.0, 32.0],
      "polymerization_at_pO2_40": "significant"
    }
  },

  "clinical_triggers": {
    "_description": "Conditions that can precipitate sickling crisis",
    "hypoxia_pO2_threshold_mmHg": 40,
    "dehydration_effect": "increases intracellular HbS concentration",
    "acidosis_effect": "further right-shifts OEC",
    "temperature_effect": "fever increases metabolism"
  }
}
